Participate in Research

TRITON Study for Adults with COPD
Protocol: STUDY00006846
Full Title
A phase III, 52-week, multinational, multicenter, randomized, double-blind, 2-arm parallel group study comparing efficacy, safety and tolerability of the fixed dose triple combination of beclomethasone dipropionate plus formoterol fumarate plus glycopyrronium bromide (CHF 5993) with the fixed dose dual combination of beclomethasone dipropionate plus formoterol fumarate (CHF 1535), both administere
The University at Buffalo (UB) Department of Medicine is looking for adults with chronic obstructive pulmonary disease (COPD) for a clinical trial. The goal of the study is to compare new combinations of bronchodilators (medications that open up the airways) and inhaled corticosteroids (anti-inflammatory medication) in people with COPD to better control their symptoms and prevent exacerbations (flare-ups).

Participants will be enrolled in the study for about 55 weeks and complete 12 in-person study visits. They will complete physical exams, lab tests, and surveys. Participants will administer the study drugs daily via inhalers. They can earn up to $728 for completing all study visits.
Compensation: Yes
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Adults 40 years or older Have been diagnosed with chronic obstructive pulmonary disease (COPD) at least 12 months before participating
Age Group: Adults
Principal Investigator: SANJAY SETHI Open Study
+1 716-888-4713
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions